OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Line 120: | Line 120: | ||
|4/23/2010 | |4/23/2010 | ||
|[[Igor Landais]] | |[[Igor Landais]] | ||
| | | Targeted cancer therapy using inhibitors of the Fanconi anemia DNA damage response pathway | ||
| [[Hoatlin Lab]] | | [[Hoatlin Lab]] | ||
|-- | |-- |
Revision as of 10:29, 7 April 2010
Home Faculty Graduate Program Postdocs OHSU Knight Core Facilities
Programs
Res Group Meetings
Cancer Journal Club
Cell/CANB 616
Gen. Inst/R3 Club
CANB 610
Objectives of the OHSU Knight Cancer Biology Research Group Meetings
Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
- Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
- Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
Knight Research Group Activities
Want to join us? All are invited!
- To get on the listserve:
- Email: majordomoATohsu.edu
- subject: subscribe oncres
- text box: subscribe oncres
- We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
- Fridays 9:30-10:30 AM - see schedule below
- Breakfast provided by the Knight!
- Organizer: Rosie Sears, email searsrATohsu.edu
Member Labs and Affiliations
Lopez Lab Hem Onc
Sears Lab, MMG
Hoatlin Lab, BMB
Thayer Lab, BMB
Lloyd Lab, CROET
McCullough Lab, CROET
- Scheduling In Progress
Schedule
Date | Presenters | Topic | Links & Comments |
09/25/2009 | Cancer Institute Research Group Mixer; prospective student welcome | ||
10/9/2009 | Brandon Hayes-Lattin | Unique Biology of Adolescent and Young Adult Cancers | |
10/23/2009 | CANCELED | PROGRAM 3 - SOLID TUMORS - RETREAT | |
11/13/2009 | Mushui Dai | Control of p53 stability and activity by deubiquitination | |
12/11/2009 | Sears Lab | Post-translational regulation of c-Myc transcriptional activity and tumorigenic potential | |
1/8/2010 | Gary Thomas | ||
1/22/2010 | CANCELLED | ||
2/12/2010 | Steve Jaques | Optical Assessment of Cancer in Research and the Clinic | |
2/26/2010 | Liu Yuangang | Molly Kulesz-Martin Lab | |
3/12/2010 | CANCELED | ||
3/26/2010 | CANCELED | Spring Break | |
4/2/2010 | Michael Ostrowski | Genetic Analysis of the "Soil" Required for Mammary Cancer Metastasis: Ets2 Function in Tumor Associated Macrophages | Professor & Chair, Department of Molecular & Cellular Biochemistry
Ohio State University |
4/9/2010 | Adam Clore and Anuradha Kumari | Amanda McCullough Lab | |
4/16/2010 | Elie Traer | Mechanisms of CML stem cell persistence in the bone marrow microenvironment | Hematology/Oncology Deininger Lab |
4/23/2010 | Igor Landais | Targeted cancer therapy using inhibitors of the Fanconi anemia DNA damage response pathway | Hoatlin Lab |
5/7/2010 | Xiangshu Xiao | ||
5/14/2010 | Lev Fedorov | "Targeting of Bub1b leads to loss of spindle checkpoint function and embryonic lethality" | Transgenic Mouse models Shared Resource |
5/28/2010 | Jared Fischer | Liskay lab | |
6/11/2010 | Marcus Monroe | Wong Lab |